메뉴 건너뛰기




Volumn 125, Issue 13, 2012, Pages 3144-3152

Various p53 mutant proteins differently regulate the ras circuit to induce a cancer-related gene signature

Author keywords

Gain of function; Mutant p53; Ras

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; PROTEIN P53; ZINC ION;

EID: 84869121043     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.099663     Document Type: Article
Times cited : (65)

References (43)
  • 1
    • 41149142016 scopus 로고    scopus 로고
    • Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol
    • Apte, R. N. and Voronov, E. (2008). Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol. Rev. 222, 222-241.
    • (2008) Rev , vol.222 , pp. 222-241
    • Apte, R.N.1    Voronov, E.2
  • 2
    • 30944459963 scopus 로고    scopus 로고
    • A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras- induced transformation
    • Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. and Gudkov, A. V. (2006). A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras- induced transformation. Genes Dev. 20, 236-252.
    • (2006) Genes Dev , vol.20 , pp. 236-252
    • Boiko, A.D.1    Porteous, S.2    Razorenova, O.V.3    Krivokrysenko, V.I.4    Williams, B.R.5    Gudkov, A.V.6
  • 3
    • 0024376173 scopus 로고
    • ras oncogenes in human cancer: a review
    • Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
    • (1989) Cancer Res , vol.49 , pp. 4682-4689
    • Bos, J.L.1
  • 4
    • 70349443284 scopus 로고    scopus 로고
    • When mutants gain new powers: news from the mutant p53 field
    • Brosh, R. and Rotter, V. (2009). When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713.
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 701-713
    • Brosh, R.1    Rotter, V.2
  • 5
    • 70349118044 scopus 로고    scopus 로고
    • p53: balancing tumour suppression and implications for the clinic
    • Buganim, Y. and Rotter, V. (2009). p53: balancing tumour suppression and implications for the clinic. Eur. J. Cancer 45 Suppl 1, 217-234.
    • (2009) Eur. J. Cancer , vol.45 , Issue.SUPPL. 1 , pp. 217-234
    • Buganim, Y.1    Rotter, V.2
  • 6
    • 77950239571 scopus 로고    scopus 로고
    • p53 regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways
    • Buganim, Y., Solomon, H., Rais, Y., Kistner, D., Nachmany, I., Brait, M., Madar, S., Goldstein, I., Kalo, E., Adam, N. et al. (2010). p53 regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. Cancer Res. 70, 2274-2284.
    • (2010) Cancer Res , vol.70 , pp. 2274-2284
    • Buganim, Y.1    Solomon, H.2    Rais, Y.3    Kistner, D.4    Nachmany, I.5    Brait, M.6    Madar, S.7    Goldstein, I.8    Kalo, E.9    Adam, N.10
  • 7
    • 0035496607 scopus 로고    scopus 로고
    • Rescuing the function of mutant p53
    • Bullock, A. N. and Fersht, A. R. (2001). Rescuing the function of mutant p53. Nat. Rev. Cancer 1, 68-76.
    • (2001) Nat. Rev. Cancer , vol.1 , pp. 68-76
    • Bullock, A.N.1    Fersht, A.R.2
  • 8
    • 0027983669 scopus 로고
    • Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations
    • Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
    • (1994) Science , vol.265 , pp. 346-355
    • Cho, Y.1    Gorina, S.2    Jeffrey, P.D.3    Pavletich, N.P.4
  • 9
    • 0036659130 scopus 로고    scopus 로고
    • Role of CXCL1 in tumorigenesis of melanoma
    • Dhawan, P. and Richmond, A. (2002). Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 72, 9-18.
    • (2002) J. Leukoc. Biol. , vol.72 , pp. 9-18
    • Dhawan, P.1    Richmond, A.2
  • 10
    • 0037264633 scopus 로고    scopus 로고
    • Targeting RAS signalling pathways in cancer therapy
    • Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 11-22
    • Downward, J.1
  • 11
    • 26444497172 scopus 로고    scopus 로고
    • Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors
    • Dreyfus, D. H., Nagasawa, M., Gelfand, E. W. and Ghoda, L. Y. (2005). Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors. BMC Immunol. 6, 12.
    • (2005) BMC Immunol , vol.6 , pp. 12
    • Dreyfus, D.H.1    Nagasawa, M.2    Gelfand, E.W.3    Ghoda, L.Y.4
  • 12
    • 0021675797 scopus 로고
    • Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
    • Eliyahu, D., Raz, A., Gruss, P., Givol, D. and Oren, M. (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312, 646-649.
    • (1984) Nature , vol.312 , pp. 646-649
    • Eliyahu, D.1    Raz, A.2    Gruss, P.3    Givol, D.4    Oren, M.5
  • 14
    • 0027212498 scopus 로고
    • Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins
    • Frangioni, J. V. and Neel, B. G. (1993). Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210, 179-187.
    • (1993) Anal. Biochem. , vol.210 , pp. 179-187
    • Frangioni, J.V.1    Neel, B.G.2
  • 15
    • 0036251645 scopus 로고    scopus 로고
    • TP53: a key gene in human cancer
    • Guimaraes, D. P. and Hainaut, P. (2002). TP53: a key gene in human cancer. Biochimie 84, 83-93.
    • (2002) Biochimie , vol.84 , pp. 83-93
    • Guimaraes, D.P.1    Hainaut, P.2
  • 17
    • 0030941458 scopus 로고    scopus 로고
    • p53, the cellular gatekeeper for growth and division
    • Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
    • (1997) Cell , vol.88 , pp. 323-331
    • Levine, A.J.1
  • 18
    • 34047223196 scopus 로고    scopus 로고
    • Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
    • Li, Y. and Prives, C. (2007). Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene 26, 2220-2225.
    • (2007) Oncogene , vol.26 , pp. 2220-2225
    • Li, Y.1    Prives, C.2
  • 19
    • 0029062595 scopus 로고
    • Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants
    • Lin, J., Teresky, A. K. and Levine, A. J. (1995). Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 10, 2387-2390.
    • (1995) Oncogene , vol.10 , pp. 2387-2390
    • Lin, J.1    Teresky, A.K.2    Levine, A.J.3
  • 20
    • 33846243857 scopus 로고    scopus 로고
    • The oncogenic roles of p53 mutants in mouse models
    • Lozano, G. (2007). The oncogenic roles of p53 mutants in mouse models. Curr. Opin. Genet. Dev. 17, 66-70.
    • (2007) Curr. Opin. Genet. Dev. , vol.17 , pp. 66-70
    • Lozano, G.1
  • 23
    • 0037805547 scopus 로고    scopus 로고
    • RAS oncogenes: the first 30 years
    • Malumbres, M. and Barbacid, M. (2003). RAS oncogenes: the first 30 years. Nat. Rev. Cancer 3, 459-465.
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 459-465
    • Malumbres, M.1    Barbacid, M.2
  • 24
    • 0030612937 scopus 로고    scopus 로고
    • Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
    • Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J. and Baldwin, A. S., Jr (1997). Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278, 1812-1815.
    • (1997) Science , vol.278 , pp. 1812-1815
    • Mayo, M.W.1    Wang, C.Y.2    Cogswell, P.C.3    Rogers-Graham, K.S.4    Lowe, S.W.5    Der, C.J.6    Baldwin Jr, A.S.7
  • 26
    • 24744464071 scopus 로고    scopus 로고
    • Expression of MMP2 MMP9 and MMP3 in breast cancer brain metastasis in a rat model
    • Mendes, O., Kim, H. T. and Stoica, G. (2005). Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis 22, 237-246.
    • (2005) Clin. Exp. Metastasis , vol.22 , pp. 237-246
    • Mendes, O.1    Kim, H.T.2    Stoica, G.3
  • 27
    • 70449109147 scopus 로고    scopus 로고
    • Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma
    • Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C. and Jacks, T. (2009). Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462, 104-107.
    • (2009) Nature , vol.462 , pp. 104-107
    • Meylan, E.1    Dooley, A.L.2    Feldser, D.M.3    Shen, L.4    Turk, E.5    Ouyang, C.6    Jacks, T.7
  • 29
    • 21144456106 scopus 로고    scopus 로고
    • Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation
    • Milyavsky, M., Tabach, Y., Shats, I., Erez, N., Cohen, Y., Tang, X., Kalis, M., Kogan, I., Buganim, Y., Goldfinger, N. et al. (2005). Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation. Cancer Res. 65, 4530-4543.
    • (2005) Cancer Res , vol.65 , pp. 4530-4543
    • Milyavsky, M.1    Tabach, Y.2    Shats, I.3    Erez, N.4    Cohen, Y.5    Tang, X.6    Kalis, M.7    Kogan, I.8    Buganim, Y.9    Goldfinger, N.10
  • 31
    • 0021673319 scopus 로고
    • Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
    • Parada, L. F., Land, H., Weinberg, R. A., Wolf, D. and Rotter, V. (1984). Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312, 649-651.
    • (1984) Nature , vol.312 , pp. 649-651
    • Parada, L.F.1    Land, H.2    Weinberg, R.A.3    Wolf, D.4    Rotter, V.5
  • 32
    • 0029891536 scopus 로고    scopus 로고
    • p53 transactivation domain mutant Q22 S23 is impaired for repression of promoters and mediation of apoptosis
    • Roemer, K. and Mueller-Lantzsch, N. (1996). p53 transactivation domain mutant Q22, S23 is impaired for repression of promoters and mediation of apoptosis. Oncogene 12, 2069-2079.
    • (1996) Oncogene , vol.12 , pp. 2069-2079
    • Roemer, K.1    Mueller-Lantzsch, N.2
  • 34
    • 0026446686 scopus 로고
    • Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding
    • Shaulian, E., Zauberman, A., Ginsberg, D. and Oren, M. (1992). Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12, 5581-5592.
    • (1992) Mol. Cell. Biol. , vol.12 , pp. 5581-5592
    • Shaulian, E.1    Zauberman, A.2    Ginsberg, D.3    Oren, M.4
  • 35
    • 0034671945 scopus 로고    scopus 로고
    • Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome
    • Sigal, A. and Rotter, V. (2000). Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788-6793.
    • (2000) Cancer Res , vol.60 , pp. 6788-6793
    • Sigal, A.1    Rotter, V.2
  • 36
    • 34247329362 scopus 로고    scopus 로고
    • p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
    • Song, H., Hollstein, M. and Xu, Y. (2007). p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell Biol. 9, 573-580.
    • (2007) Nat. Cell Biol. , vol.9 , pp. 573-580
    • Song, H.1    Hollstein, M.2    Xu, Y.3
  • 38
    • 0030957152 scopus 로고    scopus 로고
    • Li-Fraumeni syndrome - a molecular and clinical review
    • Varley, J. M., Evans, D. G. and Birch, J. M. (1997). Li-Fraumeni syndrome - a molecular and clinical review. Br. J. Cancer 76, 1-14.
    • (1997) Br. J. Cancer , vol.76 , pp. 1-14
    • Varley, J.M.1    Evans, D.G.2    Birch, J.M.3
  • 39
    • 0027250250 scopus 로고
    • Mammalian Ras interacts directly with the serine/threonine kinase Raf
    • Vojtek, A. B., Hollenberg, S. M. and Cooper, J. A. (1993). Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214.
    • (1993) Cell , vol.74 , pp. 205-214
    • Vojtek, A.B.1    Hollenberg, S.M.2    Cooper, J.A.3
  • 41
    • 34047198167 scopus 로고    scopus 로고
    • Transcription regulation by mutant p53
    • Weisz, L., Oren, M. and Rotter, V. (2007a). Transcription regulation by mutant p53. Oncogene 26, 2202-2211.
    • (2007) Oncogene , vol.26 , pp. 2202-2211
    • Weisz, L.1    Oren, M.2    Rotter, V.3
  • 43
    • 33847627873 scopus 로고    scopus 로고
    • Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
    • Xia, M. and Land, H. (2007). Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat. Struct. Mol. Biol. 14, 215-223.
    • (2007) Nat. Struct. Mol. Biol , vol.14 , pp. 215-223
    • Xia, M.1    Land, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.